Meghan Kelly Partner, Trials, Complex Litigation & Dispute Resolution
New York; Los Angeles
New York; Los Angeles
New York; Los Angeles
Meghan approaches each representation with a problem-solving mentality and comprehensive legal strategy. In an industry where many cases are settled, she has established an impressive record at trial including for chemical, pharmaceutical, automotive, biotechnology, manufacturing and food companies in their most important cases. Drawing on her winning track record in front of juries, Meghan strategically prepares clients’ cases from the beginning to put them in the best position to achieve a favorable outcome.
Paris
Julien assists listed and unlisted companies, financial institutions, investors and founders in cross-border or domestic transactions, including mergers and acquisitions, acquisition of stakes, strategic partnerships, as well as public tender offers.
Prior to joining Orrick, Julien worked on similar operations as a legal intern at international law firms in London and Paris. Julien also worked at the economic and financial section of the prosecutor’s office of the Tribunal de Grande Instance de Paris.
Los Angeles
Daniel advises private equity clients and other investors in all aspects of their real estate, real estate finance, and related matters, including purchase and sale transactions, development, mortgage and mezzanine financing, preferred equity arrangements, workouts, restructuring transactions, and joint venture formations.
He counsels clients on transactions backed by diverse asset classes throughout the United States, including multifamily, office, industrial, shopping center, data center, and hotel properties, as well as land for development.
Paris
Nolwenn’s practice focuses on debt financing transactions, including leveraged acquisition financings, for private credit funds, private equity sponsors, corporates and special situations funds.
Prior to joining Orrick, she was an associate at another leading US law firm.
Washington, D.C.
Washington, D.C.
Kayla draws on her prior experience as an attorney in the Office of Administrative Judges and Dispute Resolution at the Federal Energy Regulatory Commission (FERC) to advise clients on FERC litigation, policy, and procedure. Kayla has extensive knowledge in issues arising under the Federal Power Act, the Public Utility Holding Company Act of 2005, Public Utility Regulatory Policies Act, and the Natural Gas Act. She also represents LNG developers and natural gas pipeline companies in all aspects of FERC authorization and certificate matters. Kayla also helps clients navigate FERC-regulated wholesale energy, capacity, and ancillary services markets.
Kayla is recognized as an Associate to Watch by Chambers USA Nationwide (2025), where clients describe her as "a real asset" and that her "knowledge of FERC related matters has been very beneficial."
Los Angeles
Rome
He is Of Counsel and a member of the Technology Transactions practice in Italy.
New York
Kasey represents tech startups throughout all stages of their lifecycle. She advises on formation, general corporate and governance matters, and a broad range of transactions, such as venture capital financings, mergers and acquisitions. Kasey also advises venture capital investors on investment in their portfolio companies.
Prior to joining Orrick, Kasey was an associate in the Emerging Companies and Venture Capital Group at Fox Rothschild LLP in New York.
Washington, D.C.; New York
Washington, D.C.; New York
Walt provides counseling on financial services mergers and acquisitions, focusing on assisting private equity sponsors and strategic buyers in investments in bank and nonbank financial services firms, providing regulatory and transactional advice to identify and mitigate risk, and assisting buyers in obtaining regulatory approvals where necessary.
His work also includes a wide range of counseling and acting on behalf of clients in enforcement matters, including those involving the Consumer Financial Protection Bureau (CFPB), the Federal Trade Commission (FTC), and the prudential bank regulators, as well as state attorneys general and other state authorities.
For 14 years in a row, Walt has been ranked nationally for his work in the area of Financial Services Regulation by Chambers USA. Clients noted that "He's extremely talented and has lots of wisdom," that he is "an outstanding lawyer" and “the guy who had all the history of why and when the regulations were put in place – his knowledge is amazing," with "expertise (that) spans a range of areas, including credit cards, auto finance, and mortgage lending." He also has been named a "Leading Lawyer" by the IFLR1000 for Financial Services Regulatory in the U.S., recognized by Best Lawyers for Financial Services Regulation Law, is a Fellow of the American College of Consumer Financial Services Lawyers. He also serves as Professorial Lecturer in Law at George Washington University.
Prior to joining Orrick, Walt was a partner at Buckley LLP in the firm’s Washington, D.C., and New York offices.
San Francisco
Ana represents companies in the technology, energy, and financial sectors in a wide range of civil disputes including claims of trade secret misappropriation and breach of contract. Her practice also includes defending companies under investigation by states Attorneys General.
Prior to law school, Ana was a member of the legal team at Lyft supporting the Litigation, IP, Employment, Product/Commercial, and Corporate practice groups.
Houston
Alex has authored scientific papers in peer-reviewed publications examining the molecular basis of regenerative myogenesis and cancer-induced cachexia. His doctoral work in Anatomical Sciences and Neurobiology from the University of Louisville focused on transgenic animal studies and in vitro paradigms to discern critical signaling pathways necessary for the repair of skeletal muscle. He has extensive experience in molecular biology, including the generation of viral vectors and CRISPR/Cas9 constructs, and in performing electrophysiological recording of skeletal muscle in situ. In his postdoctoral studies, he focused his research efforts on interrogating the molecular basis for the induction the skeletal muscle wasting disorder “cachexia” in a novel model of ovarian cancer-induced cachexia.
San Francisco
San Francisco